Correction: SIRT5-modified human umbilical cord mesenchymal stem cells loaded with antioxidant polydopamine nanozyme enhance parpi resistance in ovarian cancer via fatty acid metabolism reprogramming

Key Points

• PARPi resistance is enhanced through metabolic reprogramming involving fatty acid metabolism, leading to improved treatment outcomes.
• SIRT5-modified mesenchymal stem cells were loaded with antioxidant polydopamine nanozyme to facilitate this resistance.
• The assessment used advanced cellular techniques to evaluate the impact of these modifications on ovarian cancer cells.
• Through this approach, potential new treatment strategies may be developed to combat ovarian cancer more effectively.